Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
72.57B
Market cap72.57B
Price-Earnings ratio
18.71
Price-Earnings ratio18.71
Dividend yield
Dividend yield
Average volume
22.62M
Average volume22.62M
High today
$46.80
High today$46.80
Low today
$44.44
Low today$44.44
Open price
$45.96
Open price$45.96
Volume
18.68M
Volume18.68M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $46.68. The company's market cap stands at 72.57B, with a P/E ratio of 18.71.

On 2026-07-31, Boston Scientific(BSX) stock moved within a range of $44.44 to $46.80. With shares now at $46.68, the stock is trading +5.0% above its intraday low and -0.3% below the session's peak.

Trading volume for Boston Scientific(BSX) stock has reached 18.68M, versus its average volume of 22.62M.

The stock's 52-week range extends from a low of $42.20 to a high of $109.50.

The stock's 52-week range extends from a low of $42.20 to a high of $109.50.

BSX News

Investing.com 9h
Argus downgrades Boston Scientific stock rating on product headwinds - Investing.com

...

Argus downgrades Boston Scientific stock rating on product headwinds - Investing.com
Nasdaq 1d
BSX September 11th Options Begin Trading

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the September 11th expiration. At Stock Options Channel , our YieldB...

BSX September 11th Options Begin Trading
TipRanks 1d
Boston Scientific price target lowered to $70 from $85 at RBC Capital

RBC Capital analyst Shagun Singh lowered the firm’s price target on Boston Scientific (BSX) to $70 from $85 and keeps an Outperform rating on the shares. The co...

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
15.6%
Sell
0%

More BSX News

TipRanks 1d
Boston Scientific: Buy Rating Reaffirmed as Analyst Trims Price Target to $61 but Sees Strong Long-Term Growth Reacceleration

Analyst Joanne Wuensch of Citi maintained a Buy rating on Boston Scientific, reducing the price target to $61.00. Claim 55% Off TipRanks Unlock powerful investi...

Simply Wall St 2d
Low Volatility Stocks Investors Are Watching As Fed Rate Signals Turn Less Clear

Fed Chair Kevin Warsh’s move to dial back forward guidance has left markets more data driven and, at times, more jumpy. When rate clues are harder to read, many...

Low Volatility Stocks Investors Are Watching As Fed Rate Signals Turn Less Clear
Simply Wall St 2d
Boston Scientific Stock Looks Cheap On Earnings But Weak On Execution

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the shar...

Boston Scientific Stock Looks Cheap On Earnings But Weak On Execution
TipRanks 2d
Boston Scientific Balances Earnings Beat With Cautious Outlook

Boston Scientific ((BSX)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools wit...

Benzinga 2d
Boston Scientific Cuts Forecast on Product Slowdown and Competition

Boston Scientific Corporation (NYSE:BSX) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets....

Boston Scientific Cuts Forecast on Product Slowdown and Competition
Seeking Alpha 2d
Boston Scientific slips as outlook trails consensus

Boston Scientific (BSX) lost nearly 6% in the premarket on Wednesday despite reporting better-than-expected Q2 2026 financials as the medical device maker set i...

Boston Scientific slips as outlook trails consensus
The Wall Street Journal 2d
Boston Scientific Cuts Outlook Ahead of Restructuring

Boston Scientific logged higher second-quarter results. Clodagh Kilcoyne / Reuters Boston Scientific BSX 1.21 %increase; up pointing triangle logged higher sec...

Boston Scientific Cuts Outlook Ahead of Restructuring

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.